How does Bio/Data Corporation measure its commitment to Quality and the realization to its quality goals?
Bio/Data Corporation measures its commitment to quality through timely and periodic review of the data generated by the Quality Assurance System. These reviews generate Corrective and Preventative Actions (CAPA) that improve our systems, products, and services. Timely and periodic review of reports detailing the Company’s delivery performance. The Management team develops policies and procedures for improvement if and when needed. Bio/Data Corporation supports global efforts to standardize test performance and harmonized interpretive guidelines. With laboratories around the world relying on Bio/Data Corporation’s aggregometers and reagents, lab professionals are able to provide accurate hemostasis monitoring by running platelet function and activation tests under the same conditions time after time. As a manufacturer, marketer, and distributor of hematological medical laboratory products, our Company continuously works to improve its test systems and customer satisfaction.
Related Questions
- Our suppliers are required to provide various details with their invoices so that we can measure compliance and quality can this data be captured electronically?
- My cath lab participates in the NCDR™. How does the ACC-CathKIT® help me use my NCDR data to improve quality?
- Will PreMIS be usable by local systems to query data and generate system and quality management reports?
